Last reviewed · How we verify
25% TRICHLOROACETIC ACID
At a glance
| Generic name | 25% TRICHLOROACETIC ACID |
|---|---|
| Also known as | Peeling agent |
| Sponsor | Combined Military Hospital Abbottabad |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Topical 15% Trichloroacetic Acid Versus Silver Nitrate Cauterization in the Management of Idiopathic Childhood Epistaxis: A Prospective Double-Blinded, Randomized Clinical Trial (NA)
- Efficacy of 25% Trichloroacetic Acid Peel Versus 30% Salicylic Acid Peel in Mild to Moderate Acne Vulgaris (NA)
- An In Vivo Model for Postinflammatory Hyperpigmentation (NA)
- Chemical Peels and Fractional Laser on IGF-1 Levels in Skin (NA)
- Combined Salicylic and Azaleic Acid Verus Trichloroacetic Acid 25% Peel in Treatment of Acne (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- 25% TRICHLOROACETIC ACID CI brief — competitive landscape report
- 25% TRICHLOROACETIC ACID updates RSS · CI watch RSS
- Combined Military Hospital Abbottabad portfolio CI